Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Optomed Oyj
  6. News
  7. Summary
    OPTOMED   FI4000410881


Real-time Estimate Quote. Real-time Estimate Cboe Europe - 11/29 03:19:48 am
9.91 EUR   +1.12%
11/24OPTOMED OYJ : webinar on December 9, 2021
11/08Change in Optomed's holding of treasury
11/04Optomed Oyj Provides Earnings Guidance for the Year 2021
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Optomed Oyj : Composition of Optomed's Nomination Board

09/13/2021 | 08:02am EST

Optomed Plc         Stock Exchange Release    13 September 2021 at 15:00, Helsinki

Composition of Optomed's Nomination Board

According to Optomed's shareholder register of 1 September 2021, the shareholders represented in the shareholders' Nomination Board are OP-Rahastoyhtiö Oy (OP funds), Aktia Rahastoyhtiö Oy (Aktia funds) and Finnish Industry Investment Ltd. These shareholders have appointed the following persons to the Nomination Board:

  • Vesa Vanha-Honko, OP funds
  • Markus Lindqvist, Aktia funds
  • Keith Bonnici, Finnish Industry Investment Ltd

Petri Salonen, Chairman of Optomed's Board of Directors, will serve as the Nomination Board's expert member.

According to the resolution of Optomed General Meeting, the Optomed Nomination Board consists of the representatives of Optomed three largest shareholders as of the first trading day September, and the Chairman of the Board of Directors as an expert member. Should a shareholder not wish to exercise the nomination right, the right shall be transferred to the next largest shareholder who otherwise would not be entitled to nominate a member.

The Nomination Board is to prepare proposals on the composition and members of the Board of Directors and their remuneration for the next Annual General Meeting and it will submit its proposal to the Board of Directors 31 January 2022 at the latest.

Optomed Plc

Further enquiries

Petri Salonen, Chairman of the Board, Optomed Plc, petri.salonen@optomed.com

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.


(c) 2021 Cision. All rights reserved., source Press Releases - English

All news about OPTOMED OYJ
11/24OPTOMED OYJ : webinar on December 9, 2021
11/08Change in Optomed's holding of treasury
11/04Optomed Oyj Provides Earnings Guidance for the Year 2021
11/04OPTOMED PLC : Interim report, January - September 2021
11/04Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
10/27Optomed's Jan–Sept 2021 interim report to be published on 4 November 2021
10/27Optomed's January–September 2021 interim report to be published on 4 November 202..
09/20OPTOMED OYJ(HLSE : OPTOMED) added to S&P Global BMI Index
09/13OPTOMED OYJ : Composition of Optomed's Nomination Board
09/13OPTOMED OYJ : Composition of Optomed's Nomination Board
More news
Sales 2021 15,4 M 17,3 M 17,3 M
Net income 2021 -3,63 M -4,10 M -4,10 M
Net Debt 2021 0,33 M 0,37 M 0,37 M
P/E ratio 2021 -36,3x
Yield 2021 -
Capitalization 133 M 150 M 150 M
EV / Sales 2021 8,66x
EV / Sales 2022 7,61x
Nbr of Employees 118
Free-Float 91,5%
Duration : Period :
Optomed Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPTOMED OYJ
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 9,80 €
Average target price 11,90 €
Spread / Average Target 21,4%
EPS Revisions
Managers and Directors
Seppo Henrik Kopsala Chief Executive Officer
Lars Goran Lindqvist Chief Financial Officer
Petri Paavali Salonen Chairman
Petri Huhtinen Clinical Director
Seppo Olavi Mńkinen Independent Director
Sector and Competitors